Researchers across all academic disciplines at Indiana University Bloomington are invited to submit abstracts about projects that have the potential for commercial applications. The deadline for submission is March 4.
Selected abstracts will be accepted for the second annual Bloomington Innovation Conference on March 31, organized by the Johnson Center for Innovation and Translational Research.
Submissions from all academic areas will be considered. They may describe recently completed work or the results of work in progress. Submission requirements are:
- Must be sent in PDF format to JCITR@indiana.edu.
- Must include an abstract of no more than 500 words.
- May include a draft of the poster, either in portrait or landscape format, no larger than 36″ by 46″.
- Must include the researcher’s name, university affiliation, email address and phone number.
Questions about the process of submitting an abstract can be directed to JCITR@indiana.edu or 812-855-3133.
Authors will be notified by March 21 if their abstract has been accepted to be displayed. Authors whose abstracts are chosen are responsible for costs associated with the preparation and presentation of the abstract and poster. They must attend the March 31 conference, which will be held 9 a.m. to 6 p.m. at the Frangipani Room, Indiana Memorial Union, Biddle Hotel and Conference Center, 900 E. Seventh St., Bloomington.
Keith Davis, director of the Johnson Center for Innovation and Translational Research, believes researchers will benefit by attending the conference.
“Presenters will have the opportunity to receive valuable feedback on their work through discussions with attendees from both the Bloomington campus and regional industry partners,” he said. “We see this conference as a key activity of the JCITR and hope we can foster more industry-academic collaborations in Bloomington.”
Scheduled conference speakers include Michael Hiles, vice president for research and development and chief scientific officer, Cook Biotech Inc.; Maria J. Blanco, director, discovery chemistry research & technologies, Eli Lilly & Co.; Adam Zlotnick, professor, Department of Molecular and Cellular Biochemistry and co-founder, Assembly Biosciences; and IU innovators who received funding through the JCITR Translational Re search Pilot Grant Program.